Sickle Cell Disease
Considerations
-
Multisystem disease with end-organ dysfunction:
-
CNS: stroke
-
Cardiovascular: LV hypertrophy, high-output cardiac failure (anemia), myocardial infarction without coronary artery disease
-
Respiratory: acute chest syndrome (ACS), restrictive lung disease (pulmonary fibrosis), pulmonary hypertension, RV hypertrophy, cor-pulmonale
-
Renal: renal failure, renal infarction
-
Spleen: sequestration, infarcts; if splenectomy → ↓ immunity
-
-
Potential for perioperative exacerbations of vaso-occlusive crises:
-
Acute pain crisis
-
Acute chest syndrome
-
-
Chronic hemolytic anemia:
-
Chronic RBC transfusion & its complications (alloimmunization, iron overload, viral transmission)
-
-
Chronic pain & potential opioid tolerance
-
Preoperative optimization: consider preoperative transfusion for goal hematocrit: 30%, hemoglobin: 100 (see discussion in optimization)
-
Medications: immunosuppresants, antineoplastics
Goals
-
Avoid precipitants of sickle cell crisis:
-
Hypoxia
-
Vascular stasis
-
Hypothermia
-
Hypovolemia/hypotension
-
Acidosis
-
-
Optimize perioperative pain control
-
Monitor for:
-
Vaso-occlusive crisis
-
Acute chest syndrome
-
Aplastic crisis
-
Splenic sequestration syndrome
-
Right upper quadrant syndrome
-
Optimization (in consultation with hematology)
-
Risk factors for acute pain crises:
-
Age, frequency of hospitalizations &/or transfusions for episodes of crisis, evidence of organ damage (e.g., low baseline oxygen saturation, elevated creatinine, cardiac dysfunction), history of central nervous system events, concurrent infection
-
-
Procedural risk for complications:
-
Low: minor surgery (e.g., inguinal hernia & extremity surgery)
-
Intermediate: intra-abdominal operations (e.g., cholecystectomy)
-
High: intracranial & intrathoracic procedures, hip surgery
-
-
Hematology consult, optimize treatment:
-
Hydroxyurea to ↑ fetal hemoglobin production
-
-
Cancel non-emergent cases if patient experiencing a crisis
-
Only low risk patients should be considered for outpatient surgery
-
IV fluid to avoid dehydration while NPO
-
Preoperative transfusion therapy:
-
Controversial without good evidence
-
Purpose is to correct pre-existing anemia, ↓ hemoglobin S concentration & ↑ adult hemoglobin
-
Consider target hemoglobin 100 or hematocrit 30% for intermediate & high risk surgeries & always have blood available for any surgery
-
Exchange transfusions are not routinely recommended
-
Acute chest syndrome (ACS)
-
Background:
-
Second most common reason for hospitalization after vaso-occlusive crisis
-
Mortality 2-12%; accounts for 25% of deaths in sickle cell patients
-
Characterized by acute respiratory symptoms concurrent with new infiltrate on CXR
-
Spectrum of pathology:
-
Infection
-
Infarction (especially ribs)
-
Pulmonary sequestration
-
Fat embolism
-
-
Pulmonary vaso-occlusion due to sequestration of sickled cells in small pulmonary vessels
-
Infection or fat emboli may lead to vaso-occlusion & sequestration
-
Clinical picture: fever, tachypnea, pleuritic pain & cough
-
CXR: normal to complete opacification but usually demonstrates a new lobar infiltrate:
-
Children: upper lobe disease common
-
Adults: multilobe & lower lobe disease more common
-
-
Strong relationship between ACS & stroke
-
-
Treatment:
-
Admit to monitored setting, may need ICU
-
Hydration to euvolemia
-
Oxygen, noninvasive PPV if necessary
-
Bronchodilators (even if not wheezing)
-
Broad spectrum antibiotics: infection is one of the most common causes of ACS
-
Transfusion: both simple & exchange transfusion:
-
Simple transfusion: goal is to ↑ hematocrit to > 30%:
-
Indications:
-
To improve oxygenation, particularly in patients with oxygen saturation below 92% on room air & to prevent progression to respiratory failure
-
For accentuated anemia, defined as a hematocrit that is 10% to 20% below the patient's usual hematocrit, or with a dropping hematocrit during hospitalization
-
Clinical or radiological progression of disease but not impending respiratory failure
-
For patients in whom exchange transfusion will be delayed; simple transfusions may be used to temporize the clinical situation until the exchange transfusion can be performed
-
-
-
Exchange transfusion: goal is to ↓ the level of hemoglobin S to < 30%:
-
Indications:
-
Progression of ACS despite simple transfusion
-
Severe hypoxemia
-
Multi-lobar disease
-
Previous history of severe ACS or cardiopulmonary disease
-
-
-
-
Analgesia: adequate analgesia of spine, thoracic, & abdominal pain is important to prevent hypoventilation & atelectasis
-
Possibly inhaled nitric oxide for severe cases
-
-
Acute pain crisis (Vaso-occlusive crisis)
-
Anesthesia may be requested to assist with analgesia (e.g., patient-controlled analgesia)
-
Typically occurs in long bones, ribs, spine, or abdomen
-
Precipitants: infection, dehydration, hypothermia, hypoxia, stress, alcohol intake, menstruation
-
Bone pain from ischemia & infarction of marrow or cortex
-
Abdominal pain from bowel ischemia, organ infarction, or referred from the ribs
-
Severity of pain can range from annoying to disabling
-
Treatment: rest, warmth, reassurance, analgesia, fluid replacement:
-
Oral analgesics may be sufficient for minor attacks
-
Opioids (IM, SC, IV, PO):
-
PCA opioids with baseline analgesia provided by background infusion or fentanyl patch
-
-
Acetaminophen & NSAIDs:
-
NSAIDS particularly good for bone pain
-
-
Ketamine as adjunct
-
Regional blocks as appropriate, epidural use has been reported
-
Pregnancy Considerations
-
Interaction with pregnancy:
-
Pregnancy typically exacerbates the complications of sickle cell anemia
-
Maternal mortality is as high as 1%
-
Pulmonary embolism & infection are the leading causes of death
-
-
Management:
-
Hemoglobin goals:
-
> 80 for vaginal delivery
-
> 100 for cesarean delivery
-
-
Epidural strongly recommended in labor to reduce stress/pain
-
Safe to use either GA or neuraxial for cesarean section
-
Goals: avoid hypovolemia, hypoxemia, hypercarbia, hypothermia, pain, stress
-